Getting to that Point

Illumina announced at the JP Morgan Healthcare Conference earlier this week that one of its new platforms, dubbed the HiSeq X Ten Sequencing System, could produce a human genome for $1,000.

Reaching this price point has been a long-desired goal as more affordable sequencing may herald widespread adoption of whole-genome sequencing and enable personalized medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.